Blog

Promising Results for PhasixST™ Mesh in Hiatal Hernia Repair

Using bioabsorbable PhasixST™ mesh in laparoscopic large hiatal hernia repairs shows potential to improve outcomes and reduce complications.

  • Average recurrence rate with PhasixST™ mesh is just 2.82 per 100 patients within one year.
  • No reported mesh-related complications, addressing concerns with permanent materials.

Surgeons should consider this mesh option for better patient outcomes and lower risk profiles in hiatal hernia repairs.

  • Technique focuses on careful crural reinforcement to prevent migration or erosion.

Review by Kourtidis L, Neokleous K (…) Ayiomamitis G et 14 al. in J Clin Med

read the whole article in J Clin Med

open it in PubMed

New Prognostic Tool Enhances HCC Treatment Decisions

A new CT-based online calculator predicts survival benefits from adjuvant transarterial chemoembolization after surgical resection in hepatocellular carcinoma patients.

  • 35.4% of patients evaluated may benefit from pa-tace, increasing 5-year overall survival probability by 19.4% and adding 22.5 months of restricted mean survival time.
  • The tool outperforms traditional staging systems with a c-index of 0.694 and an integrated Brier score ≤ 0.176.

Surgeons can use this online resource to tailor postoperative protocols and address high-risk patients effectively.

Journal Article by Li X, Liang X (…) Quan X et 10 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Robotic Repair Outshines Open for Biliary Duct Injuries

Robotic repair of iatrogenic biliary duct injuries offers significant advantages over traditional open surgery.

  • Significantly less blood loss with robotic repair: 51 ml vs. 314 ml (p < 0.001).
  • Shorter hospital stays: 4 days vs. 16 days (p < 0.001).

Robotic procedures had similar complication rates to open repairs with no bile leaks or strictures in the robotic group.

  • Delayed robotic repairs had longer operative times but comparable outcomes.

Comparative Study by Al Harakeh H, Odorizzi R (…) Sucandy I et 7 al. in J Robot Surg

© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

read the whole article in J Robot Surg

open it in PubMed

Spleen-Saving Techniques in Distal Pancreatectomy: Key Findings

A study comparing Warshaw vs. Kimura techniques for spleen-preserving distal pancreatectomy shows crucial differences in outcomes.

  • Warshaw is preferred for larger tumors (2.5 cm vs. 1.5 cm) and complex cases, while Kimura offers shorter operative times and is more often minimally invasive (73.1% vs. 44.1%).
  • Long-term complications like splenic hypoperfusion are more frequent after Warshaw (30.4% vs. 12.2%), though mostly asymptomatic.

Surgeons should choose technique based on tumor characteristics to minimize complications and optimize patient recovery.

  • Need for secondary splenectomy is rare at only 1.2%.

Journal Article by Arya S, Ventin M (…) Ferrone CR et 9 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Laparoscopic D2 Lymphadenectomy Improves Gastric Cancer Outcomes

Laparoscopic D2 lymphadenectomy with complete mesogastrium excision offers significant benefits for locally advanced upper gastric cancer patients.

  • Reduced intraoperative blood loss: 89.4 ml vs. 145.7 ml (p < .001).
  • Increased lymph node yield: 42.9 vs. 37.1 (p = .008).
  • Faster postoperative recovery: hospital stay of 14 days vs. 15 days (p = .035).

Patients with stage T4a particularly benefit with improved long-term survival and disease-free outcomes.

Journal Article by Liu F, Xu Y (…) Li Z et 5 al. in BMC Surg

Copyright © 2025 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Lower Dumping Syndrome Rates with Fundoring Gastric Bypass

One-anastomosis gastric bypass with modified fundoplication significantly reduces dumping syndrome compared to standard one-anastomosis gastric bypass.

  • Dumping syndrome occurred in 19.6% of the fundoring group vs. 35% in the standard group (p=0.001).
  • At one year, BMI in the fundoring group was 27.0 vs. 29.0 in the standard group (p=0.04).

Surgeons should consider the fundoring technique for reduced dumping syndrome in eligible patients, enhancing post-operative quality of life.

  • Sigstad scores were 2.8 for the fundoring group compared to 5.1 for the standard group (p=0.001).

Journal Article by Ospanov O, Danyarova L (…) Ospanova S et 4 al. in Obes Surg

© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Obes Surg

open it in PubMed

Laser Hair Treatment Cuts Pilonidal Disease Recurrence

Laser hair treatment significantly reduces recurrence of pilonidal disease in adolescents and young adults but its effectiveness varies by insurance type.

  • Patients receiving laser treatment had a 74% lower risk of disease recurrence within one year (odds ratio 0.26, p = 0.001).
  • Those with private insurance benefitted more, showing a recurrence odds ratio of 0.29, while public insurance patients did not see a benefit (odds ratio 1.20).

Understanding these factors can enhance surgical decision-making and patient counseling, particularly regarding treatment options based on insurance status.

Journal Article by Turpin AG, Asti L (…) Minneci PC et 5 al. in J Surg Res

Copyright © 2025 Elsevier Inc. All rights reserved.

read the whole article in J Surg Res

open it in PubMed

Surgery + Chemotherapy Improves Survival in Stage IV Pancreatic Cancer

Integrating surgery with chemotherapy may extend survival for some patients with stage IV pancreatic cancer and liver metastases.

  • Patients undergoing combined surgery and chemotherapy had a median overall survival of 18 months, whereas those on chemotherapy alone showed significantly less.
  • Younger patients (under 65) had a reduced mortality risk (HR = 1.3), and tumor location was a key survival predictor; those with tumors in the body (HR = 0.5) or tail (HR = 0.4) had lower mortality risks than those with head tumors.

Careful patient selection is crucial, as the observed survival benefit may reflect these factors rather than a direct treatment effect.

Journal Article by Shao S, Guo Q, Chen H and Tian B in Gland Surg

Copyright © 2025 AME Publishing Company. All rights reserved.

read the whole article in Gland Surg

open it in PubMed

Management Strategies for Acute Cholecystitis in Surgical Non-Candidates

Surgeons need to adapt to novel treatments for acute cholecystitis (AC) when surgery isn’t an option.

  • Percutaneous cholecystostomy is recommended for patients unfit for lumen-apposing metal stents, aiming to transition to cholecystectomy.
  • Endoscopic ultrasound-guided gallbladder drainage is advised for never-surgical candidates if conditions allow monitored anesthesia.

Multidisciplinary protocols are essential, though variability exists in institutional practices. Further research is necessary to validate these emerging techniques.

Review by Baron TH, Jorge I (…) Riaz A et 10 al. in Ann Surg

Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Neoadjuvant Therapy Outperforms Upfront Surgery for Pancreatic Cancer

Neoadjuvant chemotherapy with gemcitabine and S-1 significantly improves survival for patients with resectable pancreatic ductal adenocarcinoma compared to upfront surgery.

  • Median overall survival: 37.0 months (nac-gs) vs. 26.6 months (ups); hazard ratio for mortality: 0.73.
  • Median relapse-free survival: 14.3 months (nac-gs) vs. 11.3 months (ups); hazard ratio for relapse: 0.77.

Consider neoadjuvant therapy in surgical planning to enhance patient outcomes.

Comparative Study by Unno M, Motoi F (…) Kosuge T et 12 al. in Ann Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Ann Surg

open it in PubMed